Las Vegas, January 9, 2024 /PRNewswire/ — Movano Health (Nasdaq: MOVE), a pioneer in medical technology, and ams OSRAM, a leader in biometric monitoring technology, have teamed up to integrate ams OSRAM into Evie Ring, a smart ring designed by Movano Health. Built-in PPG sensor solution. Especially for women.
With the goal of bringing high-quality data to the forefront of consumer health devices, Movano Health’s first wearable for women, the Evie Ring, is a personalized solution designed specifically for women and Provides medical grade data measurements of critical vitals. Understand your overall health on demand. Evie Ring is the 2024 CES Innovation Award Winner in the Wearables category.
ams OSRAM’s complete PPG sensor solution consists of an optical front end (OFE) SFH 7014c emitter and SFH 2705 detector technology and the company’s analog front end (AFE) AS7057, which can deliver increased total radiated intensity. Masu. It has over 40% more photodetector surface area than previous generation products and is significantly larger than competitive products. This allows for more sensitive and accurate readings and overcomes the challenges faced by all biometric monitoring devices: minute modulation of small optical signals, scattering within tissues and As a result of absorption, accurate detection of the amount of light emitted by the LED is overcome. . This supports her Evie objective of providing a uniquely built device for women’s fingers.
“Our world-class engineers designed the Evie ring for women, who typically have smaller fingers and less blood flow. To ensure a best-in-class experience when collecting data from your fingers, we use state-of-the-art “We needed a solution for both the optical and analog side. The ams OSRAM solution allows us to meet the unique needs of our consumers.” Michael Liebman, Founder and CTO of Movano Health. “Ensuring accurate signals equals providing reliable results and actionable insights.”
“The advanced features of our precise optical sensor and analog front end enable compact yet highly accurate PPG (photoplethysmography) systems.Through carefully engineered technology, we have achieved the industry’s smallest We are able to offer a complete PPG sensor solution consisting of an analog front end for the market leading end sensor AS7057 with compact multi-emitter SFH 7014c and SFH 2705 for accurate health monitoring. “Movano Heath’s exceptional design and appeal of women-first solutions make it the ideal partner for innovative health monitoring in wearable devices,” explained Dr. Markus AlzbergerCSA IOS Automotive & Senior Director vital signs (CSA IOS AVS), ams OSRAM.
Movano Health successfully launched Evie Ring. November 20, 2023, introduced the solution at CES Unveiled last weekend. Evie rings are available exclusively at www.eviering.com.
About Movano Health
Founded in 2018, Movano Inc. (Nasdaq: MOVE) dba Movano Health develops a suite of purpose-driven healthcare solutions that bring high-quality medical-grade data to the forefront of consumer health devices. Featuring the latest form factors, Movano Health’s devices capture a comprehensive picture of a person’s critical health information and uniquely transform that data into personalized, intelligent insights to help consumers become healthier. Allowing you to live a more balanced life. Movano Health’s end-to-end solutions will soon enable consumers and their healthcare professionals to use daily medical-grade data as a tool to proactively monitor and manage their health. For more information about Movano Health, please visit https://movanohealth.com/.
Forward-looking statements
This press release contains forward-looking statements regarding our expectations, expectations, intentions, beliefs or strategies regarding the future. These forward-looking statements are based on assumptions made by the Company as of the date hereof and are subject to known and unknown conditions that may cause actual results, conditions, or events to differ materially from those anticipated. subject to risks and uncertainties. Therefore, you should not place undue reliance on forward-looking statements. Examples of forward-looking statements include, among other things, statements regarding the Company’s plans regarding the commercial launch of Evie Ring. Planned cost reduction initiatives. FDA approval of Evie Ring and other products in development is anticipated. Forecast of future performance. product development and features, product releases, clinical trials and regulatory initiatives; our strategy, positioning and expectations for future events and performance; Important factors that could cause actual results to differ materially from those in the forward-looking statements include the Company’s most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q and filings with the Company. and other reports. Securities and Exchange Commission (including under the caption “Risk Factors”). The forward-looking statements contained in this release speak only as of the date of this release. The Company undertakes no obligation to publicly update any forward-looking statements, whether written or oral, made from time to time, whether as a result of new information, future developments or otherwise.
source movano